Titre : Thérapie comportementale

Thérapie comportementale : Questions médicales fréquentes

Termes MeSH sélectionnés :

Erectile Dysfunction
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Thérapie comportementale : Questions médicales les plus fréquentes", "headline": "Thérapie comportementale : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Thérapie comportementale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-14", "dateModified": "2025-03-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Thérapie comportementale" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Psychothérapie", "url": "https://questionsmedicales.fr/mesh/D011613", "about": { "@type": "MedicalCondition", "name": "Psychothérapie", "code": { "@type": "MedicalCode", "code": "D011613", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Thérapie de maitrise de la colère", "alternateName": "Anger Management Therapy", "url": "https://questionsmedicales.fr/mesh/D000067449", "about": { "@type": "MedicalCondition", "name": "Thérapie de maitrise de la colère", "code": { "@type": "MedicalCode", "code": "D000067449", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.087" } } }, { "@type": "MedicalWebPage", "name": "Analyse comportementale appliquée", "alternateName": "Applied Behavior Analysis", "url": "https://questionsmedicales.fr/mesh/D000072357", "about": { "@type": "MedicalCondition", "name": "Analyse comportementale appliquée", "code": { "@type": "MedicalCode", "code": "D000072357", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.131" } } }, { "@type": "MedicalWebPage", "name": "Thérapie aversive", "alternateName": "Aversive Therapy", "url": "https://questionsmedicales.fr/mesh/D001348", "about": { "@type": "MedicalCondition", "name": "Thérapie aversive", "code": { "@type": "MedicalCode", "code": "D001348", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.174" } } }, { "@type": "MedicalWebPage", "name": "Thérapie cognitive", "alternateName": "Cognitive Behavioral Therapy", "url": "https://questionsmedicales.fr/mesh/D015928", "about": { "@type": "MedicalCondition", "name": "Thérapie cognitive", "code": { "@type": "MedicalCode", "code": "D015928", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.350" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Thérapie d'acceptation et d'engagement", "alternateName": "Acceptance and Commitment Therapy", "url": "https://questionsmedicales.fr/mesh/D064869", "about": { "@type": "MedicalCondition", "name": "Thérapie d'acceptation et d'engagement", "code": { "@type": "MedicalCode", "code": "D064869", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.350.249" } } }, { "@type": "MedicalWebPage", "name": "Restructuration cognitive", "alternateName": "Cognitive Restructuring", "url": "https://questionsmedicales.fr/mesh/D000088686", "about": { "@type": "MedicalCondition", "name": "Restructuration cognitive", "code": { "@type": "MedicalCode", "code": "D000088686", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.350.375" } } }, { "@type": "MedicalWebPage", "name": "Pleine conscience", "alternateName": "Mindfulness", "url": "https://questionsmedicales.fr/mesh/D064866", "about": { "@type": "MedicalCondition", "name": "Pleine conscience", "code": { "@type": "MedicalCode", "code": "D064866", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.350.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Remédiation cognitive", "alternateName": "Cognitive Remediation", "url": "https://questionsmedicales.fr/mesh/D000072466", "about": { "@type": "MedicalCondition", "name": "Remédiation cognitive", "code": { "@type": "MedicalCode", "code": "D000072466", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.365" } } }, { "@type": "MedicalWebPage", "name": "Désensibilisation psychologique", "alternateName": "Desensitization, Psychologic", "url": "https://questionsmedicales.fr/mesh/D003887", "about": { "@type": "MedicalCondition", "name": "Désensibilisation psychologique", "code": { "@type": "MedicalCode", "code": "D003887", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.506" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Désensibilisation et reprogrammation par mouvements oculaires", "alternateName": "Eye Movement Desensitization Reprocessing", "url": "https://questionsmedicales.fr/mesh/D057169", "about": { "@type": "MedicalCondition", "name": "Désensibilisation et reprogrammation par mouvements oculaires", "code": { "@type": "MedicalCode", "code": "D057169", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.506.162" } } }, { "@type": "MedicalWebPage", "name": "Thérapie implosive", "alternateName": "Implosive Therapy", "url": "https://questionsmedicales.fr/mesh/D007171", "about": { "@type": "MedicalCondition", "name": "Thérapie implosive", "code": { "@type": "MedicalCode", "code": "D007171", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.506.325" } } }, { "@type": "MedicalWebPage", "name": "Thérapie par réalité virtuelle", "alternateName": "Virtual Reality Exposure Therapy", "url": "https://questionsmedicales.fr/mesh/D063367", "about": { "@type": "MedicalCondition", "name": "Thérapie par réalité virtuelle", "code": { "@type": "MedicalCode", "code": "D063367", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.506.662" } } } ] }, { "@type": "MedicalWebPage", "name": "Thérapie comportementale dialectique", "alternateName": "Dialectical Behavior Therapy", "url": "https://questionsmedicales.fr/mesh/D000077252", "about": { "@type": "MedicalCondition", "name": "Thérapie comportementale dialectique", "code": { "@type": "MedicalCode", "code": "D000077252", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.628" } } }, { "@type": "MedicalWebPage", "name": "Thérapie par la relaxation", "alternateName": "Relaxation Therapy", "url": "https://questionsmedicales.fr/mesh/D012064", "about": { "@type": "MedicalCondition", "name": "Thérapie par la relaxation", "code": { "@type": "MedicalCode", "code": "D012064", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.750" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Méditation", "alternateName": "Meditation", "url": "https://questionsmedicales.fr/mesh/D019122", "about": { "@type": "MedicalCondition", "name": "Méditation", "code": { "@type": "MedicalCode", "code": "D019122", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.750.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Chronothérapie sur les phases de sommeil", "alternateName": "Sleep Phase Chronotherapy", "url": "https://questionsmedicales.fr/mesh/D055865", "about": { "@type": "MedicalCondition", "name": "Chronothérapie sur les phases de sommeil", "code": { "@type": "MedicalCode", "code": "D055865", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137.875" } } } ], "about": { "@type": "MedicalCondition", "name": "Thérapie comportementale", "alternateName": "Behavior Therapy", "code": { "@type": "MedicalCode", "code": "D001521", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Daniel F Gros", "url": "https://questionsmedicales.fr/author/Daniel%20F%20Gros", "affiliation": { "@type": "Organization", "name": "Mental Health Service, Ralph H. Johnson VA Healthcare System, Charleston, South Carolina, USA." } }, { "@type": "Person", "name": "Tanja van der Zweerde", "url": "https://questionsmedicales.fr/author/Tanja%20van%20der%20Zweerde", "affiliation": { "@type": "Organization", "name": "Department of Clinical Psychology, EMGO Institute for Health and Care Research, VU University, Van der Boechorststraat 7, Amsterdam 1081 BT, the Netherlands. Electronic address: t.vander.zweerde@vu.nl." } }, { "@type": "Person", "name": "Jaap Lancee", "url": "https://questionsmedicales.fr/author/Jaap%20Lancee", "affiliation": { "@type": "Organization", "name": "Department of Clinical Psychology, University of Amsterdam, Nieuwe Achtergracht 129, Amsterdam 1018 WS, the Netherlands; PsyQ Amsterdam, Amsterdam, the Netherlands." } }, { "@type": "Person", "name": "Annemieke van Straten", "url": "https://questionsmedicales.fr/author/Annemieke%20van%20Straten", "affiliation": { "@type": "Organization", "name": "Department of Clinical Psychology, EMGO Institute for Health and Care Research, VU University, Van der Boechorststraat 7, Amsterdam 1081 BT, the Netherlands." } }, { "@type": "Person", "name": "Shireen L Rizvi", "url": "https://questionsmedicales.fr/author/Shireen%20L%20Rizvi", "affiliation": { "@type": "Organization", "name": "Rutgers University. Electronic address: slrizvi@gsapp.rutgers.edu." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Genetic Evidence Supporting a Causal Role of Snoring in Erectile Dysfunction.", "datePublished": "2022-05-25", "url": "https://questionsmedicales.fr/article/35692403", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2022.896369" } }, { "@type": "ScholarlyArticle", "name": "Comparison of characteristics between Chinese diabetes mellitus-induced erectile dysfunction populations and non-diabetes mellitus-induced erectile dysfunction populations: A cross-sectional study.", "datePublished": "2022-12-21", "url": "https://questionsmedicales.fr/article/36619568", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2022.1096045" } }, { "@type": "ScholarlyArticle", "name": "Clinical efficacy of intracavernous injection of platelet lysate for erectile dysfunction.", "datePublished": "2024-10-29", "url": "https://questionsmedicales.fr/article/39472866", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12894-024-01633-2" } }, { "@type": "ScholarlyArticle", "name": "High prevalence of erectile dysfunction in men with hyperthyroidism: a meta-analysis.", "datePublished": "2024-04-30", "url": "https://questionsmedicales.fr/article/38689308", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12902-024-01585-6" } }, { "@type": "ScholarlyArticle", "name": "The Association Between 2, 4-Dichlorophenoxyacetic Acid and Erectile Dysfunction.", "datePublished": "2022-06-24", "url": "https://questionsmedicales.fr/article/35812473", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2022.910251" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Disciplines et activités comportementales", "item": "https://questionsmedicales.fr/mesh/D004191" }, { "@type": "ListItem", "position": 3, "name": "Psychothérapie", "item": "https://questionsmedicales.fr/mesh/D011613" }, { "@type": "ListItem", "position": 4, "name": "Thérapie comportementale", "item": "https://questionsmedicales.fr/mesh/D001521" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Thérapie comportementale - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Thérapie comportementale", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Thérapie comportementale", "description": "Comment diagnostiquer un besoin de thérapie comportementale ?\nQuels tests sont utilisés pour le diagnostic ?\nQui peut poser un diagnostic pour cette thérapie ?\nQuels critères sont utilisés pour le diagnostic ?\nLa thérapie comportementale est-elle adaptée à tous ?", "url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Erectile+Dysfunction&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Thérapie comportementale", "description": "Quels symptômes indiquent un besoin de thérapie comportementale ?\nComment les symptômes varient-ils selon les individus ?\nLes symptômes physiques sont-ils liés à la thérapie comportementale ?\nLes symptômes peuvent-ils s'aggraver sans traitement ?\nQuels sont les signes d'amélioration avec la thérapie ?", "url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Erectile+Dysfunction&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Thérapie comportementale", "description": "Comment prévenir les troubles nécessitant une thérapie comportementale ?\nLes programmes scolaires peuvent-ils aider à la prévention ?\nQuels rôles jouent les parents dans la prévention ?\nLa prévention est-elle possible à l'âge adulte ?\nLes groupes de soutien peuvent-ils aider à la prévention ?", "url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Erectile+Dysfunction&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Thérapie comportementale", "description": "Quelles techniques sont utilisées en thérapie comportementale ?\nCombien de séances sont généralement nécessaires ?\nLa thérapie comportementale peut-elle être combinée avec d'autres traitements ?\nQuels sont les objectifs principaux de cette thérapie ?\nLa thérapie comportementale est-elle efficace pour les enfants ?", "url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Erectile+Dysfunction&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Thérapie comportementale", "description": "Quelles complications peuvent survenir sans traitement ?\nLa thérapie comportementale peut-elle entraîner des effets secondaires ?\nQuels risques de rechute existent après la thérapie ?\nLes complications psychologiques peuvent-elles affecter la santé physique ?\nComment minimiser les complications après la thérapie ?", "url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Erectile+Dysfunction&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Thérapie comportementale", "description": "Quels facteurs augmentent le risque de troubles comportementaux ?\nL'environnement familial influence-t-il les comportements ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe manque de soutien social est-il un facteur de risque ?\nLes événements de vie stressants augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Erectile+Dysfunction&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un besoin de thérapie comportementale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un professionnel évalue les comportements problématiques et leur impact sur la vie quotidienne." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des questionnaires et des entretiens cliniques sont souvent utilisés pour évaluer les comportements." } }, { "@type": "Question", "name": "Qui peut poser un diagnostic pour cette thérapie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Un psychologue, un psychiatre ou un thérapeute qualifié peut poser ce diagnostic." } }, { "@type": "Question", "name": "Quels critères sont utilisés pour le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les critères incluent la fréquence, l'intensité et l'impact des comportements sur la vie." } }, { "@type": "Question", "name": "La thérapie comportementale est-elle adaptée à tous ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elle est efficace pour de nombreux troubles, mais un diagnostic précis est essentiel." } }, { "@type": "Question", "name": "Quels symptômes indiquent un besoin de thérapie comportementale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des comportements compulsifs, des phobies ou des troubles d'anxiété peuvent indiquer ce besoin." } }, { "@type": "Question", "name": "Comment les symptômes varient-ils selon les individus ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent varier en intensité et en type selon les expériences personnelles." } }, { "@type": "Question", "name": "Les symptômes physiques sont-ils liés à la thérapie comportementale ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes physiques comme des palpitations peuvent accompagner des troubles psychologiques." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils s'aggraver sans traitement ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sans traitement, les symptômes peuvent s'intensifier et affecter la qualité de vie." } }, { "@type": "Question", "name": "Quels sont les signes d'amélioration avec la thérapie ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une réduction des comportements problématiques et une meilleure gestion des émotions sont des signes." } }, { "@type": "Question", "name": "Comment prévenir les troubles nécessitant une thérapie comportementale ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par l'éducation émotionnelle et le développement de compétences sociales dès le jeune âge." } }, { "@type": "Question", "name": "Les programmes scolaires peuvent-ils aider à la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des programmes de sensibilisation et de gestion des émotions dans les écoles peuvent être bénéfiques." } }, { "@type": "Question", "name": "Quels rôles jouent les parents dans la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les parents peuvent enseigner des stratégies de gestion du stress et des comportements positifs à leurs enfants." } }, { "@type": "Question", "name": "La prévention est-elle possible à l'âge adulte ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques de gestion du stress et de résolution de problèmes peuvent prévenir l'apparition de troubles." } }, { "@type": "Question", "name": "Les groupes de soutien peuvent-ils aider à la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les groupes de soutien offrent un espace pour partager des expériences et apprendre des stratégies de prévention." } }, { "@type": "Question", "name": "Quelles techniques sont utilisées en thérapie comportementale ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques comme le conditionnement opérant, l'exposition et la restructuration cognitive sont courantes." } }, { "@type": "Question", "name": "Combien de séances sont généralement nécessaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le nombre de séances varie, mais 10 à 20 séances sont souvent recommandées pour des résultats significatifs." } }, { "@type": "Question", "name": "La thérapie comportementale peut-elle être combinée avec d'autres traitements ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est souvent combinée avec des médicaments ou d'autres formes de thérapie pour une efficacité accrue." } }, { "@type": "Question", "name": "Quels sont les objectifs principaux de cette thérapie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les objectifs incluent la modification des comportements inadaptés et l'amélioration des compétences d'adaptation." } }, { "@type": "Question", "name": "La thérapie comportementale est-elle efficace pour les enfants ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est souvent utilisée pour traiter des troubles chez les enfants, comme l'anxiété et les phobies." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir sans traitement ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Sans traitement, les troubles peuvent s'aggraver, entraînant des problèmes relationnels et professionnels." } }, { "@type": "Question", "name": "La thérapie comportementale peut-elle entraîner des effets secondaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Généralement, elle n'a pas d'effets secondaires physiques, mais des émotions intenses peuvent survenir." } }, { "@type": "Question", "name": "Quels risques de rechute existent après la thérapie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des rechutes peuvent survenir si les compétences acquises ne sont pas pratiquées régulièrement." } }, { "@type": "Question", "name": "Les complications psychologiques peuvent-elles affecter la santé physique ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles psychologiques non traités peuvent entraîner des problèmes de santé physique, comme des maladies cardiaques." } }, { "@type": "Question", "name": "Comment minimiser les complications après la thérapie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La pratique continue des compétences apprises et le soutien social aident à minimiser les complications." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de troubles comportementaux ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme le stress, l'hérédité et des événements traumatiques augmentent le risque." } }, { "@type": "Question", "name": "L'environnement familial influence-t-il les comportements ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un environnement familial instable ou conflictuel peut contribuer au développement de troubles." } }, { "@type": "Question", "name": "Les antécédents médicaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de troubles mentaux dans la famille peuvent augmenter le risque de troubles comportementaux." } }, { "@type": "Question", "name": "Le manque de soutien social est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un manque de soutien social peut exacerber les troubles et rendre la gestion plus difficile." } }, { "@type": "Question", "name": "Les événements de vie stressants augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des événements comme un divorce ou la perte d'un emploi peuvent déclencher des troubles comportementaux." } } ] } ] }

Sous-catégories

16 au total

Sources (10000 au total)

Genetic Evidence Supporting a Causal Role of Snoring in Erectile Dysfunction.

The association between snoring and erectile dysfunction (ED) is inconsistent in multiple observational studies. To clarify the causal association of snoring on ED, we performed this two-sample Mendel... The single nucleotide polymorphisms (SNPs) associated with snoring were retrieved from the UK biobank cohort with 314,449 participants (117,812 cases and 196,637 controls). The summary statistics of E... Snoring increases the risk of ED (Odds ratio [OR] = 3.45, 95% confidence interval [CI] = 1.68 - 7.09,... This study provides genetic evidence supporting the causal role of snoring in ED....

Comparison of characteristics between Chinese diabetes mellitus-induced erectile dysfunction populations and non-diabetes mellitus-induced erectile dysfunction populations: A cross-sectional study.

Erectile dysfunction (ED) is a common disease in adult men, and diabetes is an independent risk factor for ED. However, there are few reports on the distinction between diabetes mellitus-induced erect... A total of 365 ED patients treated at two clinics in China from 2019 to 2022 were included. Questionnaires of the International Index of Erectile Function (IIEF-5), Erectile Hardness Score (EHS), Prem... Age (P<0.001), height (P=0.009), body mass index (BMI) (P=0.002), PEDT (P<0.001), FBG (P<0.001), FSH (P<0.001), TG (P<0.001), TT (P<0.001) and triglyceride-glucose index (TyG) (P<0.001) were significa... The aetiology, demographic parameters, degree of premature ejaculation, and related biochemical tests were significantly different between the DMED and non-DMED populations....

Clinical efficacy of intracavernous injection of platelet lysate for erectile dysfunction.

Among the emerging treatments for erectile dysfunction (ED), platelet-rich plasma (PRP), known for its ability to enhance tissue repair and regeneration, stands out as a promising therapeutic approach... We enrolled twenty-six patients, aged between 35 and 70 years (mean age 51.6 ± 11.3 years), who had been experiencing ED for over six months and had an International Index of Erectile Function-5 (IIEF... Before treatment, the mean EHS was 2.15 ± 0.88 and IIEF-5 was 10.92 ± 5.28. Remarkable improvements were observed post-treatment, with the EHS significantly increasing to 3.15 ± 0.83 (p < 0.05) and II... Our findings indicate that intracavernous injections of PL substantially enhance erectile function, as evidenced by improvements in EHS, IIEF-5, and the RI of penile Doppler ultrasound, without hemorr... The study received approval from the Institutional Review Board of National Taiwan University Hospital (IRB Number 202008061RIPC, date of registration 08/28/2020)....

High prevalence of erectile dysfunction in men with hyperthyroidism: a meta-analysis.

The objective of this study was to evaluate the association between hyperthyroidism and the risk of developing erectile dysfunction (ED).... A comprehensive search of multiple databases, including PubMed, Embase, Cochrane, and Web of Science, was conducted to identify relevant studies investigating the relationship between hyperthyroidism ... A total of four papers encompassing 25,519 study subjects were included in the analysis. Among these, 6,429 individuals had hyperthyroidism, while 19,090 served as controls. The overall prevalence of ... Our findings demonstrate a higher incidence of ED in patients with hyperthyroidism. These results provide valuable information for healthcare professionals and can facilitate discussions surrounding a...

The Association Between 2, 4-Dichlorophenoxyacetic Acid and Erectile Dysfunction.

2, 4-dichlorophenoxyacetic acid (2,4-D) is one of the most frequently used herbicides in the world, and it has been linked with low testosterone; however, studies regarding its effect on erectile func... We analyzed data for urinary 2,4-D levels from 1,311 men (>20 years of age) in the NHANES 2001-2004. ED was assessed by a single, validated survey question. Multivariable logistic regression analysis ... Multivariable logistic regression models demonstrated no statistically significant association between 2,4-D exposure and ED after full adjustment [odds ratio (OR) 1.02; 95% CI 0.77-1.36;... We demonstrated that there was no association between 2,4-D exposure and ED. Further studies are warranted to corroborate our results....

Traumatic masturbation and erectile dysfunction: A matched case-control study.

To identify atypical masturbatory behaviors (AMB) and to reveal their effects on both sexual and masturbational erection hardness in men with erectile dysfunction (ED).... Patients with ED and healthy controls were questioned about their masturbation habits. Accordingly, "rubbing in a prone position," "pressure on penis," and "masturbation through clothes" were included... The data of 448 participants, 266 (59%) from the patient group, and 182 (41%) from the control group were analyzed. The mean ages were 30 years in both groups (p = 0.734). The rate of "rubbing in a pr... Atypical masturbatory behaviors are more common in young men presenting with erectile dysfunction. These patients have higher erection hardness scores during masturbation compared to partnered sex....

Prevalence of erectile dysfunction in Thai scleroderma patients and associated factors.

Erectile dysfunction (ED) has been reported among patients with systemic sclerosis (SSc) and primarily limited cutaneous SSc in Caucasians. While there is no data on ED among Thais in whom the diffuse... We aimed to estimate the prevalence of ED among Thais with SSc, evaluate its severity, and determine the associated factors.... We did a cross-sectional study among adult Thai male SSc patients. All eligible patients: a) completed the IIEF-15 questionnaire by themselves; b) underwent a genital examination by an experienced uro... A total of 60 male SSc patients were included. The respective mean age and median disease duration was 54.8±7.2 years and 3.1 years (IQR 1.2-7.2). The definition of ED was fulfilled in 53 cases for a ... ED is a common problem in men with SSc and is mainly categorized as severe. The severity of SSc might increase the risk of developing ED. We found phimosis was a common genital abnormality co-occurrin...

Significance of detailed hematological parameters as markers of arteriogenic erectile dysfunction.

Several hematologic parameters have been shown to be strongly associated with cardiovascular disease, yet few studies were conducted to assess their relationship with atherogenic erectile dysfunction.... To find out the differences in hematological parameters between patients with atherogenic erectile dysfunction and healthy controls through as comprehensive a hematological examination as possible and... We collected hematological parameters in detail from 105 healthy controls and 183 patients with erectile dysfunction (119 patients with atherogenic erectile dysfunction patients and 64 patients with v... Statistically significant differences were found between the atherogenic erectile dysfunction and venous erectile dysfunction groups in platelet to lymphocyte ratio, neutrophil to lymphocyte ratio, an... Several hematological parameters (white blood cell, platelet to lymphocyte ratio, neutrophil to lymphocyte ratio, mean platelet volume, triglycerides, high-density lipoprotein cholesterol, and non-hig...

Effects of diet and antihyperglycemic drugs on erectile dysfunction: A systematic review.

Erectile dysfunction is recognized as one of the complications of diabetes mellitus. To date, a wide gap of knowledge is present on the efficacy of pharmacological treatments of diabetes mellitus on e... We aimed to explore the effects of diet and antihyperglycemic drugs, considering both old and novel therapeutic approaches, on erectile function.... We performed a systematic review, following the PRISMA guidelines. The research was conducted on studies reporting erectile dysfunction assessment in subjects with diabetes and the relationship with d... The Mediterranean diet was effective in most studies for the protection of erectile function. Furthermore, antihyperglycemic drugs seem to show an overall protective role on erectile function.... Although encouraging results are present for all classes of antihyperglycemic drugs, several studies are needed in humans, mainly on acarbose, pioglitazone, dipeptidyl-peptidase-4 inhibitors, and sodi...